NSECertificate under SEBI (Depositories and Participants) Regulations, 20187 Oct 2026 · 7 Oct 2026, 07:04 pm
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Strides Pharma Science Limited · STAR
✦ AI Summary
Strides Pharma Science Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk5/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Strides Pharma Science Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026
Attachments (1)
📄pdf
Download →
STRIDES_07102026185728_SE_Intimation.pdf
View document text
October 7, 2026
National Stock Exchange of India Limited BSE Limited
Exchange Plaza, Bandra-Kurla Complex, Phiroze Jeejeebhoy Towers,
Bandra (E), Mumbai - 400 051. Dalal Street, Mumbai – 400 001.
Scrip Code: STAR Scrip Code: 532531
Dear Sir/ Madam,
Sub: Certificate in terms of regulation 74(5) of SEBI (Depositories and Participants)
Regulations, 2018.
In compliance with regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, we
hereby enclose a copy of the certificates received from KFin Technologies Limited, the Registrar and
Share Transfer Agent of Strides Pharma Science Limited (the “Company”), for the quarter ended
September 30, 2026.
Kindly take the same on record.
Thanks & Regards,
For Strides Pharma Science Limited,
Manjula Ramamurthy
Company Secretary & Compliance Officer
ICSI Membership No. A30515
Strides Pharma Science Limited
CIN: L24230MH1990PLC057062
Corp. Off: Strides House, Bilekahalli, Bannerghatta Road, Bengaluru – 560 076, India |Tel: +91 80 6784 0000
Regd. Off: ‘Cyber One’, Unit No. 902, Plot No. 4&6, Sector 30A, Vashi, Navi Mumbai – 400 703, India | Tel: +91 22 2789 2924/3199
corpcomm@strides.com; www.strides.com
KFIN/STR/NSDL/74(5) E/1
Date: 02‐10‐2026
NATIONAL SECURITIES DEPOSITORY LIMITED
TRADE WORLD 4TH FLOOR
KAMALA MILLS COMPOUND
SENAPATI BAPAT MARG
LOWER PAREL
MUMBAI ‐ 400 013
Dear Sir(s),
Sub: Certificate under Regulation 74(5) for the quarter ended September 30,2026
We as Registrar to an Issue and Share Transfer Agent of the STRIDES PHARMA SCIENCE LIMITED,
certify that the details of securities dematerialized/rematerialized during the aforesaid period, as
required under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been
furnished to all the Stock Exchanges where the shares of the company are listed.
Thanking You
Yours faithfully,
for KFIN TECHNOLOGIES LIMITED
VAGOLU RATNA BABU
ASSISTANT VICE PRESIDENT
CC TO:
STRIDES PHARMA SCIENCE LIMITED
CYBER ONE, UNIT NO. 902
PLOT NO. 4 & 6
SECTOR 30A, VASHI
NAVI MUMBAI
400703
KFIN/STR/CDSL/74(5) E/1
Date: 02‐10‐2026
CENTRAL DEPOSITORY SERVICES (INDIA) LIMITED
REGD OFF: MARATHON FUTUREX, A WING
25TH FLOOR
NM JOSHI MARG
LOWER PAREL (EAST)
MUMBAI ‐ 400 023
Dear Sir(s),
Sub: Certificate under Regulation 74(5) for the quarter ended September 30,2026
We as Registrar to an Issue and Share Transfer Agent of the STRIDES PHARMA SCIENCE LIMITED,
certify that the details of securities dematerialized/rematerialized during the aforesaid period, as
required under Regulation 74(5) of SEBI (Depositories and participants) Regulations 2018 have been
furnished to all the Stock Exchanges where the shares of the company are listed.
Thanking You
Yours faithfully,
for KFIN TECHNOLOGIES LIMITED
VAGOLU RATNA BABU
ASSISTANT VICE PRESIDENT
CC TO:
STRIDES PHARMA SCIENCE LIMITED
CYBER ONE, UNIT NO. 902
PLOT NO. 4 & 6
SECTOR 30A, VASHI
NAVI MUMBAI
400703